Qatar Biomedical Research Institute (QBRI) | HBKU

Research at QBRI

The Neurological Disorders Research Center (NDRC) at QBRI focuses on research in neurological disorders of high prevalence in Qatar and pan-Arabic region

Learn More

The Diabetes Research Center (DRC) at QBRI, is working for the improved prevention, reversal, and treatment of diabetes and related complications and comorbidities, contributing to the Qatar national diabetes research, strategy, and health priorities research programs.

Learn More

The Translational Oncology Research Center aims to achieve a better understanding of the cellular and molecular bases of cancer initiation and progression with a focus on breast cancer, which is the most common type of cancer among females globally.

Learn More

QBRI’s core facilities are positioned as modern, efficient, reliable, and tightly networked shared resource laboratories that guarantee optimal support and scientific progression on several levels.

Learn More

News and Insights

Boy holding jigsaw puzzle

Advancing the Future of Autism Care: The Pivotal Role of Community Engagement and Support for Autism Research...

29 Apr 2025
Read more
Researcher at QBRI

QBRI and Sultan Qaboos University Publish Latest Collaborative Autism Study

24 Apr 2025
Read more
Breaking fast during Ramadan

Fasting During Ramadan with Type 2 Diabetes: What You Need to Know

16 Mar 2025
Read more

HBKU’s QBRI Collaborates with MoEHE to Inspire Future Biomedical Researchers

25 Feb 2025
Read more
Summer Research Program participants conduct tests in a QBRI laboratory.

HBKU’s QBRI Opens Applications for 2025 Summer Research Program

19 Feb 2025
Read more

QBRI Promotes Breast Cancer and Diabetes Awareness Through Successive Campaigns

17 Feb 2025
Read more
QBRI collaborated with the Shafallah Center for Children with Disabilities to enroll 50 Qatari autistic children and their parents in the study

QBRI Identifies 13 Novel Autism-risk Genes in Qatari Population

05 Jan 2025
Read more
Using AI speeds up diagnosis and improves outcomes.

Integrating AI into ADHD and Autism Diagnostics

29 Dec 2024
Read more
Medical pills, prescription, glucose meter and stethoscope on desk in doctor’s office.

QBRI Partners with PHCC and QCRI to Combat Prediabetes Through New Screening Tool

19 Nov 2024
Read more

Partners

As a global center for biomedical and translational research, QBRI continues to actively leverage common interests through partnerships and long-term collaborations with renowned national and international institutions.

QBRI stands as a biomedical research institute dedicated to addressing pressing health challenges in the region. Recognizing the underrepresentation of Arab populations in research, our mission extends beyond borders. We aspire to elevate QBRI into a global nexus for biomedical and translational research, fostering extensive collaborations worldwide. I take pride in our endeavors, propelling us towards enhancing healthcare in Qatar and beyond.

Dr. Omar Albagha

Acting Executive Director

Uniquely positioned within Qatar’s biomedical R&D landscape, QBRI serves as a cornerstone for excellence in research, entrepreneurial innovation, and clinical translation in the areas of cancer, diabetes, and neurological disorders—key health challenges with significant unmet needs in the local population. As Director of QBRI’s Translational Oncology Research Center (TORC), my ambition is to advance the development and implementation of precision oncology in Qatar. I aim to foster multi-level collaborations and elevate TORC’s basic, translational, and clinical research, with the ultimate goal of delivering groundbreaking discoveries and targeted therapies to cancer patients.

Dr. Vladimir L. Katanaev

Scientific Director, Translational Oncology Research Center

QBRI features multi-interdisciplinary infrastructures and aims to enhance health care management for diabetes, cancer, and neurological disorders by conducting cutting-edge research and translating discoveries into clinical settings—thereby improving patient well-being and enabling the implementation of precision medicine. As Scientific Director of the Diabetes Research Center (DRC), I aspire to propel the DRC to a new level in line with global scientific standards, mobilize international collaborations, drive breakthroughs in precision diabetes care, and develop effective strategies for the prevention and intervention of metabolic disorders such as obesity.

Dr. Cong-Yi (CY) Wang

Principle Investigator and Scientific Director, Diabetes Research Center